AVTX
Avalo Therapeutics Inc
15.70$
+2.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 376.05 | 4,271.01 | 1,517.87 | 340.09 | 262.59 | 149.15 | 460.46 | 6.93 | 0.04 | 0.00 | |
| 24.62 | 30.41 | 2,687.12 | 97.61 | 619.37 | -28.54 | 11.76 | 41.20 | 87.60 | 4.62 | -0.03 | 0.03 | |
| -24.62 | -30.41 | -2,311.07 | 4,173.40 | 898.50 | 368.63 | 250.83 | 107.96 | 372.86 | 2.30 | 0.07 | 0.00 | |
| 31.72 | 8,522.23 | 3,310.38 | 671.46 | 479.26 | 592.68 | 1,261.93 | 1,653.31 | 798.63 | 49.63 | 4.83 | 3.74 | |
| 12.63 | 5,722.46 | 2,310.09 | 1,219.52 | 884.29 | 510.00 | 682.76 | 635.54 | 526.38 | 36.97 | 1.53 | 1.67 | |
| 44.36 | 14,244.68 | 5,620.48 | 2,040.44 | 2,444.79 | 1,181.64 | 250.83 | 2,377.41 | 1,327.92 | 100.79 | 6.43 | 5.44 | |
| -44.36 | -14,244.68 | -5,244.43 | 2,132.96 | -3,256.07 | -813.01 | -1,056.52 | -2,269.46 | -955.05 | -98.48 | -6.35 | -5.44 | |
| 3.13 | 1,026.24 | 151.39 | 3.69 | 67.22 | 146.46 | 1,542.08 | 66.07 | 106.37 | 12.30 | 0.31 | – | |
| -41.61 | -13,571.91 | -5,371.95 | 2,124.72 | -3,320.09 | -805.59 | -2,633.26 | -2,336.08 | -1,061.94 | -113.53 | -3.25 | -5.83 | |
| -2.75 | -703.19 | 118.76 | 301.98 | -2.81 | 14.12 | -109.48 | -5.42 | 0.71 | 0.05 | 0.01 | 0.01 | |
| -41.61 | -13,571.91 | -5,371.95 | 1,822.74 | -3,317.28 | -809.74 | -2,489.12 | -2,331.41 | -1,062.65 | -113.58 | -3.26 | -5.84 | |
| -44.28 | -13,531.08 | -5,235.69 | 2,202.84 | -1,082.62 | -680.63 | -1,781.62 | -2,224.23 | -951.33 | -83.84 | -3.23 | -5.80 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.